October 17, 2017

Adventist Health System Partners With Glytec to Enhance Diabetes Care

The health system will utilize Glytec’s eGlycemic Management System® at 39 of its acute care facilities.

More than a quarter of all hospitalized patients in the U.S. have diabetes, and typically, these patients stay longer, experience more infections and have higher readmission rates.* Recognizing the unique challenges of caring for patients with diabetes, Adventist Health System, one of the largest faith-based health systems in the U.S., has partnered with Glytec, a leader in diabetes therapy management software and medication optimization, to implement the eGlycemic Management System® (eGMS®) at 39 of its acute care facilities.

June 21, 2017

With Glytec, Hospital Moves to Basal-Bolus Insulin, Saves $9.7 Million

The move to quality ratings will put more pressure on hospitals to find ways to improve the standard of care while cutting costs.

A decade ago, the American Diabetes Association (ADA) called for hospitals to shift from sliding scale to subcutaneous basal-bolus insulin therapy for non-critically ill patients, but change has been slow in coming. Fear of hypoglycemia and concerns that staff would not be able to keep up with dosing demands of basal-bolus kept hospitals from upgrading to the standard of care.

April 26, 2017

Research Study from Emory University Observes $3,654 Per Patient Cost Savings for CABG Surgery

Drs. Umpierrez and Cardona publish economic and clinical results of the GLUCO-CABG trial, leveraging Glytec’s Glucommander™ for personalized insulin dosing.

A study from Emory University published in the April 2017 issue of Journal of Diabetes and Its Complications (Cardona, et al. 2017) observes a near-20% reduction in perioperative complications, a 1.2-day reduction in ICU stay and a $3,654 reduction in per-patient hospitalization costs for coronary artery bypass graft (CABG) surgery. The reported outcomes, which included no severe hypoglycemia less than 40 mg/dL, were derived from an intensive glycemic control protocol supported by Glytec’s Glucommander™ for personalized insulin dosing.

February 7, 2017

Novant Health Partners with Glytec to Advance Leadership Position in Patient-Centered Diabetes Care

Glytec’s solution will enable the 14-hospital health system to achieve best practice, reduce variability and standardize care for patients with diabetes.

Becoming a national leader in diabetes care is a commitment Novant Health, headquartered in Winston-Salem, North Carolina, will advance through a new partnership with Glytec. The company’s patented eGlycemic Management System® (eGMS®) will be a focal point of the health system’s diabetes service line, offering clinicians a comprehensive set of tools, technologies and processes proven to achieve full adoption of basal-bolus insulin therapy, the standard of care and best practice endorsed by the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE).

January 25, 2017

Grady Health System Improves Diabetes Care With Glytec’s eGlycemic Management System

Glytec’s system for personalized diabetes therapy management translates to better quality of care at Atlanta’s Grady Health System.

In its quest to ensure high quality care for critically ill patients, Atlanta’s Grady Health System has implemented the evidence-based Glytec eGlycemic Management System® (eGMS®), a personalized diabetes therapy management solution.

December 20, 2016

Digital Insulin Management Cuts Hospital Readmissions for CV Patients

The findings come as CMS targets cardiac procedures in both its hospital readmission reduction program and in a bundled payment model set to take effect July 1, 2017.

Glytec, which has FDA clearance for a cloud-based system to manage insulin dosing, selected MSHA as a research site for its electronic glucose management system, or eGMS. According to the studies Parsons and Mumpower presented in November at the Diabetes Technology Meeting showcase, eGMS produced sharp drops in readmission rates in 3 areas of cardiac care.

November 14, 2016

Dramatic Readmission Reductions for CABG, CHF and AMI Attributed to Glytec’s eGlycemic Management System

Two studies presented at the 16th Annual Diabetes Technology Meeting showcase readmission reductions as high as 68% with Glytec’s solution.

Two new studies presented at last week’s Diabetes Technology Meeting further validate the ability of Glytec’s eGlycemic Management System® (eGMS®) to achieve dramatic readmission reductions for patient populations at the center of new at-risk and value-based reimbursement models, including the CMS Hospital Readmission Reduction Program (HRRP) and impending bundled payment for coronary artery bypass graft surgery (CABG).

October 5, 2016

CHI Franciscan Updating Glucose Management Tools, Seeking Robust EHR Integration

CHI Franciscan Health is preparing to implement a new SaaS-based glucose management system that offers proprietary insulin dosing algorithms, analytics and reporting, automated surveillance and alerting, but the real selling point was more seamless EHR integration.

The perceived value of medical devices and ancillary software systems is increasingly tied to how seamlessly they integrate with EHR platforms from Epic or Cerner. That was the case when CHI Franciscan Health in Tacoma, Wash., recently evaluated glucose management systems. One key reason the eight-hospital system chose to implement Glytec’s eGlycemic Management System (eGMS) was its robust integration with Epic.

September 30, 2016

Hawaii Pacific Health Receives 2016 HIMSS Enterprise Davies Award Based in Part on Success With Glytec’s eGMS®

Our client, Hawaii Pacific Health, was named a HIMSS Enterprise Davies Award recipient based in part on its success implementing Glytec’s eGlycemic Management System® to support computer-based insulin dosing and a new hypoglycemia protocol.

The results were better glucose control with computer-directed insulin dosing system versus usual care. 39.8% of all glucose values in the ICU setting were above the recommended limit (glucose 180 mg/dl) with usual care. With computer-directed insulin dosing system for intravenous insulin, the hyperglycemia rate was much lower representing just 16.6% of all glucose values.

September 22, 2016

CHI Franciscan Health Selects Glytec’s eGMS® for Precision Diabetes Management

The eGMS® solution suite includes real-time insulin dosing, robust analytics and reporting, automated surveillance and alerting, clinical transformation services, and more.

CHI Franciscan Health of Tacoma, Washington has recently turned to Glytec for its comprehensive eGlycemic Management System®, or eGMS®, which includes FDA-cleared technology for both intravenous and subcutaneous real-time insulin dosing.

September 13, 2016

Palmetto Health to Use Glytec’s eGlycemic Management System® for Diabetes Care

The FDA-cleared technology solution will help facilitate best practices for glycemic management across the integrated health care system.

Palmetto Health, the largest integrated health care system in the South Carolina Midlands region, has selected Glytec’s eGlycemic Management System®, or eGMS®, to support quality of care for patients with diabetes. The cloud-hosted eGMS® software-as-a-service (SaaS) solution will be used enterprise-wide, across all of Palmetto Health’s clinical disciplines.

May 16, 2016

Orange Regional Medical Center Receives HIMSS Stage 7 Award Based Largely on Glytec’s Insulin Decision Support Solution

Our client, Orange Regional Medical Center, received a HIMSS Analytics Stage 7 Award based largely on its success implementing Glytec’s eGlycemic Management System® to support computer-based precision insulin dosing.

HIMSS Analytics® awarded Orange Regional Medical Center (ORMC), in Middletown, N.Y., with a Stage 7 Award. The award represents ORMC’s attainment of the highest level on the Electronic Medical Record Adoption Model (EMRAM)℠.

March 16, 2016

Nationally-Recognized Riverside Medical Center Selects Glytec as Part of its Ongoing Commitment to Clinical Excellence

Hospital to leverage Glytec’s eGMS ®solution for advanced glycemic management decision support.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions, announced today that Riverside Medical Center (RMC), has selected the company’s eGlycemic Management System® (eGMS®) to further strengthen its Diabetes Management Program. eGMS® enables providers, payers and patients to control glucose levels and combat the well-documented, spiraling complications and costs associated with diabetes and hyperglycemia.

March 8, 2016

Putting Epic’s EHR to Work: Hawaii Pacific Executives on the Intersection of Health IT & Quality

We started on this journey because we identified patients with diabetes and their comorbidities as top reasons for readmissions and longer length of stay.

These patients are also at higher risk for postoperative complications. We looked at how our system was managing hyperglycemia. We looked at glucose values for all of our patients. The EHR makes that possible. Looking at the data, I was quite concerned. We had a lot of patients with hyperglycemia. There have been a lot of conversations at the American College of Surgeons National Surgical Quality Improvement Program meetings about hyperglycemia. Starting from there, we found a program [Glytec] to integrate into our EHR — something that could help with hyperglycemia management.

October 20, 2015

Hartford HealthCare Selects Glytec’s eGMS® for Diabetes Management

Hartford HealthCare will deploy the company’s eGlycemic Management System® (eGMS®) across its five hospitals.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions central to effective diabetes management, announced today that Hartford HealthCare will deploy the company’s eGlycemic Management System® (eGMS®) across its five hospitals. eGMS® enables providers, payers and patients to control glucose levels and combat the well-documented, spiraling complications and costs associated with diabetes and hyperglycemia.

June 4, 2015

37 More Hospitals Elect to Strengthen Their Diabetes Management Programs with Glytec

Company continues dramatic growth driven by its unprecedented, proven results.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions central to effective diabetes management, announces 13 additional health systems across the U.S. have recently selected the company’s eGlycemic Management System® (eGMS®). Collectively, they represent 37 new hospital implementations. eGMS® enables providers, payers, and patients to control glucose levels, and combat the well-documented, spiraling complications and costs associated with diabetes and hyperglycemia.

October 9, 2014

Woodridge Seeing Great Glycemic Results from Using Glucommander

As part of Mountain States’ Corporate Glycemic Initiative, they implemented Glucommander, a computerized insulin dosing software, to get a better handle on patient glucose levels.

The Mountain States psychiatric facility invariably has patients who need their blood sugar monitored, but people at Woodridge aren’t in the same clinically controlled environment as patients in most hospitals. They aren’t bed-bound with an IV in their arm, and nobody monitors exactly what, when and how much they eat. Thus, it’s harder to control their blood sugar levels.

September 30, 2014

These Algorithms Reduce Readmissions

Using glycemic management software that integrates with its EHR system, a Virginia hospital system has achieved a 79% improvement over the national average for hyperglycemia rates.

Doctors and nurses following the standard of care in hospitals aren’t just paying more attention to analytics. These days, the algorithm can be the cornerstone of superior care. Consider the tricky process of controlling the glycemic levels of patients with diabetes. At eight-hospital, Virginia-based Sentara Healthcare, this translates into a 79% improvement over the national average for hyperglycemia rates. These hospitals have achieved an overall hypoglycemia rate of 0.83 percent, which hospital officials says is a remarkable blended rate for IV and subcutaneous insulin therapy.

May 28, 2014

Glucose Management System Improves Standard of Care at Sentara

Hospitals have often had trouble managing patients with hyperglycemia and hypoglycemia. To help remedy that problem, Sentara Healthcare has ushered in a new standard of care in glucose management.

In 2008, Sentara saw several of its patients die due to poor management of their diabetes. There were several devastating events of prolonged hypoglycemia that resulted in permanent brain damage for patients, says Paul Chidester, M.D., vice president of medical affairs at the Va.-based Sentara Norfolk General Hospital within the health system. Sentara had reached a point when it knew it needed to do something to improve the care of its diabetes patients. “We sort of tolerated poor control of hyperglycemia and viewed episodes of hypoglycemia as a rite of passage of being in the hospital,” Chidester admits. [We said] poor control happens, just live with it. We then realized the negative impact that had on our patients, and decided that it had to change.”

May 16, 2014

E-Check of Sugar Aids in Inpatient Hypoglycemia Control

Electronic monitoring of blood sugar levels may diminish hypoglycemia and reduce length of stay in hospitalized diabetic ketoacidosis (DKA) patients, researchers reported here.

In one study, patients monitored with the Glucommander system reduced episodes of hypoglycemia by 56%, Joseph Aloi, MD, director of the Strelitz Diabetes Center at Eastern Virginia Medical School in Norfolk, and colleagues reported at the American Association of Clinical Endocrinologists meeting here. In a second study, they showed that the same system reduced the overall hospital length of stay by nearly 2 1/2 days in patients with diabetic ketoacidosis.